Skip to content

daVinci Digital Therapeutics

  • Home
  • DTx Blog
  • DTx Newsletter
  • News
  • Pipeline
  • Events
  • DTxDay20
  • Contact us
  • Home
  • DTx Blog
  • DTx Newsletter
  • News
  • Pipeline
  • Events
  • DTxDay20
  • Contact us

daVinci Digital Therapeutics

a Digital Biotech Company

COVID-19 Adjustment disorders

Recent Posts

  • White paper reveals pathway for digital therapeutics use in Italy
  • Digital Therapeutics, an Opportunity for Italy
  • Digital Therapeutics Day 2020 – Where Are We Now? We Are We Going?
  • Startup – Corporate collaboration to develop DTx
  • What are DTx Digital Excipients?
  • The New Era of Programmable Medicines
  • Programmable Medicines and Digital Biotechnology
  • Digital Therapeutics – What They Are, What They Will Be
  • Digital Therapeutic to Treat Adjustment Disorders during COVID-19
  • FDA has approved Somryst, a Digital Therapeutic to treat chronic insomnia
  • Research & Development of Digital Therapeutics

daVinci Digital Therapeutics
Via Giovanni Durando 38
20158 Milan – I
+ 39 02 2399 2985
https://davincidtx.com

Digital Therapeutics Day 2020 #DTxDAY20

https://www.youtube.com/watch?v=LVLd8gkuZuo&list=PLZQ1y6mMVircvV7EwcK4vLLHM0vW9r6Br&index=1&t=45s

ARCHIVES

  • February 2021
  • January 2021
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020

CATEGORIES

  • COVID-19
  • Digital Health
  • R&D
  • Research

Partnerships

Privacy Policy

Code of Ethics

daVinci Digital Therapeutics srl, Milan 2020